Scribe Therapeutics is the latest biotech to prepare a public listing, as the company looks to propel its lipid-lowering medicines through clinical trials. While the Bay Area biotech has yet to set ...
Newsable Asianet News on MSN
Morgan Stanley Warns Chip Stocks Momentum Is Fading, Favors Three Hyperscalers — JPMorgan Says AI ‘Unlikely’ To Be Only Trade In Town
According to a Bloomberg report citing a Morgan Stanley note, the firm picked Microsoft, Amazon, and Meta as its favorites ...
July 6 (Reuters) - Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are ...
Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...
Hyperscalers may benefit as chip stocks struggle, according to Morgan Stanley strategists. The once-hot semiconductor trade has seen a cooling in the last couple of weeks, which is not only likely to ...
Hyperscalers may benefit as chip stocks struggle, according to Morgan Stanley strategists. The once-hot semiconductor trade has seen a cooling in the last couple of weeks, which is not only likely to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results